PRTN3 and diffuse large B-cell lymphoma: In conclusion, our study demonstrated a higher prevalence of ACPA in DLBCL patients compared with healthy controls, but our results do not suggest that the targeted clinical application of ACPA evaluation in DLBCL would be useful.